Edmonton, Alberta, August 1, 2023– The Canadian CMV Foundation is delighted to announce
their support of the Alberta Government’s commitment to invest $6 million in expanding the
Alberta Newborn Screening Program. This strategic allocation will enable the addition of five
critical conditions, including congenital cytomegalovirus (CMV), argininosuccinic aciduria,
guanidinoacetate methyltransferase deficiency, mucopolysaccharidosis type 1, and
3-hydroxy-3-methylglutaryl-CoA lyase to the screening panel.
The inclusion of congenital cytomegalovirus (CMV) in the Alberta Newborn Screening Program
is a significant milestone in promoting the health and well-being of newborns across the
province. CMV is one of the most common viral infections in newborns and can lead to severe
health issues if not detected and managed early on. By screening for CMV at birth, we have a
unique opportunity to intervene promptly and initiate appropriate medical care, potentially
mitigating the impact of this virus on infants and their families.
“We commend the Alberta Government for prioritizing the importance of early detection and
intervention for babies affected by congenital CMV and other life-altering congenital diseases,”
stated Lisa Robinson and Lindsay Craig, Albertan parent advocates for the Canadian CMV
Foundation. “The investment of $6 million to add these five additional conditions to the Alberta
Newborn Screening Program demonstrates the government’s commitment to the health and
well-being of its maternal and newborn population.”
The Canadian CMV Foundation, along with the entire medical community, welcomes this
initiative and remains committed to supporting the Alberta Government in its efforts to
enhance the well-being of its youngest citizens. We look forward to witnessing the positive
impact of the expanded screening program in the lives of Alberta families.
About the Canadian CMV Foundation
The Canadian CMV Foundation is a non-profit organization dedicated to raising awareness
about congenital cytomegalovirus (CMV), advocating for universal screening, supporting
affected families, and funding research for better diagnostic and treatment options.
For more information, visit cmvcanada.com or email info@cmvcanada.com.
Letter of Support Templates
Email your letters of support to: health.minister@gov.ab.ca
